Search for: "United States v. Abbott Laboratories" Results 81 - 100 of 141
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market… [read post]
6 Jul 2010, 6:03 pm by Duncan
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market… [read post]
7 Apr 2010, 3:44 pm by admin
Click Here EPA Settles with Drug and Laboratory Disposal on Hazardous Waste Violations. [read post]
31 Oct 2009, 4:06 pm by admin
Paul, United States Magistrate Judge Jeanne Graham fined the company $100,000 and ordered it to make a $50,000 community service payment to the Minnesota Department of Natural Resources to benefit the Rice Creek Watershed. [read post]
11 Sep 2009, 10:33 am
At the DIDA site, under Document Sources, you can read about some of those drug company lawsuits, in particular: United States of America ex rel. [read post]
3 Sep 2009, 6:44 pm
Abbott Laboratories, 297 F.3d 544 (7th Cir. 2002); United States v. [read post]
5 Jul 2009, 2:23 pm
After a reported five hours of deliberation, the jury in Centocor Inc v Abbott Laboratories awarded the Johnson & Johnson unit $1.67 billion for Abbott's willful infringement. [read post]
29 Jun 2009, 2:59 pm
Docket: 08-645 Title: Abbott v. [read post]
10 Jun 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Afro-Indian anti-counterfeit legislation debate; Legislation prompts India to send delegation to Africa (Spicy IP) (Afro-IP) (Afro-IP) Drug seizures in Frankfurt spark fears of EU-wide pattern (Intellectual Property Watch)   General Broad plan on IP, innovation in developing countries approved at WHO (Intellectual Property Watch) World… [read post]
10 Jun 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Afro-Indian anti-counterfeit legislation debate; Legislation prompts India to send delegation to Africa (Spicy IP) (Afro-IP) (Afro-IP) Drug seizures in Frankfurt spark fears of EU-wide pattern (Intellectual Property Watch)   General Broad plan on IP, innovation in developing countries approved at WHO (Intellectual Property Watch) World… [read post]
4 Jun 2009, 5:30 am
One would have expected that these reforms to have brought the...Patent SOS: Inequitable Conduct Reform ASAPNot long ago the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
25 May 2009, 5:20 pm
(The IP Factor) Israel Patent Office practice regarding legal expenses in oppositions (The IP Factor)   New Zealand New Zealand launches second ACTA consultation (Michael Geist)   United Kingdom EWHC request for summary judgment denied - OHIM-IPO class heading conflict case: Daimler v Sany (IPKat)   United States US General Trade secret litigation on the rise against laid off employees (Silicon Valley IP Licensing Law Blog) Seeking and… [read post]
21 May 2009, 10:03 am
  Regardless of whether we elect John McCain or Barack Obama, my hope is that we can get someone who actually knows a thing...Patent SOS: Inequitable Conduct Reform ASAPNot long ago the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]